Thompson Davis & Co’s Xylem XYL Stock Holding History

Thompson Davis & Co’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-150	Closed	-$8K	–	1187
2017 Q1	$8K	Buy	+150	New	+$7.31K	0.01%	779

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Thompson Davis & Co's XYL Position: Q2 2017 in Review

Thompson Davis & Co sold out of Xylem (XYL) in Q2 2017, closing a stake of 150 shares — an estimated $8K sold.

Thompson Davis & Co first reported a position in XYL in Q1 2017 and held it in 1 quarter. The position peaked at $8K in Q1 2017. 549 funds tracked by Wall St. Rank hold XYL as of Q2 2017.

Thompson Davis & Co reported no remaining Xylem position as of Q2 2017 after selling out during the quarter.
Thompson Davis & Co sold 150 Xylem shares in Q2 2017, an estimated $8K.
Thompson Davis & Co first reported a position in Xylem in Q1 2017 and held it in 1 quarter.
Thompson Davis & Co's Xylem position peaked at $8K in Q1 2017.
549 funds tracked by Wall St. Rank held Xylem as of Q2 2017.

Based on Thompson Davis & Co's 13F filing for Q2 2017, filed 10 Aug 2017.